11βHSD1 inhibition with AZD4017 improves lipid profiles and lean muscle mass in Idiopathic intracranial hypertension

Rowan S Hardy
, Hannah Botfield
, Keira Markey
, James L Mitchell
, Zerin Alimajstorovic
, Connar S J Westgate
, Michael Sagmeister
, Rebecca J Fairclough
, Ryan S Ottridge
, Andreas Yiangou
, Karl-Heinz H Storbeck
, Angela E Taylor
, Lorna C Gilligan
, Wiebke Arlt
, Paul M. Stewart
, Jeremy W Tomlinson
, Susan P Mollan
, Gareth G Lavery
, Alexandra J Sinclair^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

375 Downloads (Pure)

2 results

Filter

Finished
Assessing the Therapeutic Efficacy of an 11Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in Idiopathic Intracranial Hypertension (IIH)
Sinclair, A. (Principal Investigator), Tomlinson, J. (Co-Investigator) & Stewart, P. (Co-Investigator)
Medical Research Council
12/08/13 → 11/08/17
Project: Research Councils
Sustained treatment of Idiopathic Intracranial Hypertension (IIH) through weight loss induced by bariatric surgery
Sinclair, A. (Principal Investigator)
NIHR TRAINEES COORDINATING CENTRE
1/06/13 → 31/10/18
Project: Research